Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

被引：0
|
作者：
Parind B. Patel
Stephen J. Brett
David O’Callaghan
Aisha Anjum
Mary Cross
Jane Warwick
Anthony C. Gordon
机构：
[1] Imperial College Healthcare NHS Trust,Centre for Perioperative Medicine and Critical Care Research
[2] Imperial College London,Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer
[3] Imperial College London,Imperial Clinical Trials Unit, School of Public Health, Faculty of Medicine
[4] University of Warwick,Warwick Clinical Trials Unit
来源：
Intensive Care Medicine | 2020年 / 46卷
关键词：
Methylnaltrexone; Constipation; Laxatives; Critical care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 755
页数：8
相关论文
共 50 条
  • [1] Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial
    Patel, Parind B.
    Brett, Stephen J.
    O'Callaghan, David
    Anjum, Aisha
    Cross, Mary
    Warwick, Jane
    Gordon, Anthony C.
    INTENSIVE CARE MEDICINE, 2020, 46 (04) : 747 - 755
  • [2] Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION)
    Patel, Parind B.
    Brett, Stephen J.
    O'Callaghan, David
    Anjum, Aisha
    Cross, Mary
    Warwick, Jane
    Gordon, Anthony C.
    BMJ OPEN, 2016, 6 (07):
  • [3] Methylnaltrexone: Treatment for Opioid-Induced Constipation
    Licup, Nerissa
    Baumrucker, Steven J.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2011, 28 (01): : 59 - 61
  • [4] Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation in cancer patients.
    Mori, M.
    Ashikaga, T.
    Grunberg, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Methylnaltrexone in the treatment of opioid-induced constipation
    Greenwood-Van Meerveld, Beverley
    Standifer, Kelly M.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2008, 1 : 49 - 58
  • [6] Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients
    Kyle, Gaye
    INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2009, 15 (11) : 533 - 540
  • [7] Use of Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Critical Care Patients
    Sawh, Sergio B.
    Selvaraj, Ibrahim P.
    Danga, Akila
    Cotton, Alison L.
    Moss, Jonathan
    Patel, Parind B.
    MAYO CLINIC PROCEEDINGS, 2012, 87 (03) : 255 - 259
  • [8] Methylnaltrexone treatment of opioid-induced constipation in cancer patients
    Karver, S. B.
    Slatkin, N. E.
    Thomas, J.
    Israel, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Methylnaltrexone for the treatment of opioid-induced constipation
    Bader, Sabine
    Duerk, Thorsten
    Becker, Gerhild
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (01) : 13 - 26
  • [10] METHYLNALTREXONE BROMIDE IN THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN LUNG CANCER PATIENTS. IS IT EFFECTIVE?
    Dimitroulis, Ioannis A.
    Dervas, Agisilaos
    Vasileiou, Sofia
    Toumbis, Michalis
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S204 - S204
12345